NetworkNewsBreaks

ThursdayJun 06, 2024 2:09 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Raises ~$2.7M in Warrant Inducement Offering

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, recently closed on a warrant inducement offering. The company received gross proceeds of $2,786,174 from the transaction. Aegis Capital Corp. acted as the exclusive placement agent for the offering. To view the Form 8-K filing, visit https://nnw.fm/CnGjG About SOBRsafe(TM) Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way. Enter SOBRsafe(TM), where advanced…

Continue Reading

ThursdayJun 06, 2024 2:04 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Spotlighted in Most Recent “New to the Street” Episode

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a premier Swiss-hosted secure and private communications platform, is featured in this week’s Weekly Hack segment of FMW Media's New to the Street. The program is slated to air on Bloomberg TV tonight at 9:30 PM PT. During the Weekly Hack portion of the show, Sekur Private Data CEO and internet privacy expert Alain Ghiai talked with program host Ana Berry about the joint cybersecurity advisory issued by the FBI, NSA and U.S. State Department regarding foreign state-sponsored email hackings and attacks. In the statement, the agencies shared the belief that North Korean military…

Continue Reading

ThursdayJun 06, 2024 1:57 pm

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Cargo Management Group Acquisition, Focuses on Long-Term Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. According to the announcement, the transaction involved using 10% of the profits from GTVH’s logistics business to buy back and retire GTVH stock, which effectively reduced the number of outstanding shares on a consistent basis as profits are realized. This move represents Golden Triangle Ventures focus on driving long-term value for its shareholders. The company noted that Cargo Management Group reported nearly $3 million in revenue for 2023; the acquisition is expected to streamline internal operations, yield…

Continue Reading

ThursdayJun 06, 2024 1:39 pm

NetworkNewsBreaks – Mushrooms Inc. (MSRM) Completes 5M Share Buy Bank, Reports on  Development of Bacterial Detection Bandage

Mushrooms (OTC: MSRN), a leading innovator in biotechnology and sustainable healthcare solutions using mushrooms and mycelium, has purchased five million shares of stock from an affiliate. The company announced that the transaction had been conducted by the board, with no loans required and no costs to the company; the stocks will be used to advance the company’s strategic initiatives, preventing further dilution. The company also announced the development and expected shipment of mycelium-based materials to the research team in Germany. The shipment, which is expected to happen later this summer, marks the first step in the development of the company’s…

Continue Reading

ThursdayJun 06, 2024 12:48 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Onboards 26 New Customers and 149 New Carriers YTD

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has announced it has added 26 new customers and 149 new carriers to its platform in 2024. According to the announcement, the roster of new customers extends Fr8Tech’s footprint across its core markets and service offerings. “The addition of new customers to our platform further demonstrates the need for greater efficiency and transparency in the freight, over-the-road…

Continue Reading

WednesdayJun 05, 2024 3:57 pm

NetworkNewsBreaks – Bluejay Diagnostics Inc. (NASDAQ: BJDX) Secures ~$2.2M in Private Placement

Bluejay (NASDAQ: BJDX) is a medical diagnostics company that offers the Symphony technology platform, Symphony Cartridge and tests and testing devices for the diagnosis of allergic conjunctivitis and monitoring of disease progression in critical care settings. Aegis Capital Corp. announced that it acted as exclusive placement agent on a ~$2.2 million private placement for Bluejay Diagnostics. To view the Form 8-K filing, visit https://nnw.fm/QhhGP About Bluejay Diagnostics Inc. Bluejay operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force;…

Continue Reading

WednesdayJun 05, 2024 3:48 pm

NetworkNewsBreaks – Astiva Health Inc. to Host Summer Gala

Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan dedicated to reshaping personalized and comprehensive healthcare, today announced the Astiva Health Summer Gala, to be held at its headquarters in Orange, California. The event marks a significant milestone for the company and is slated to take place from 5 p.m. to 10 p.m. PT on June 29, 2024. The gala will feature live music, a dynamic atmosphere, as well as an important announcement concerning the company’s future plans. A keynote address by Astiva Health’s executive team will highlight strategic initiatives as the company continues its journey towards excellence…

Continue Reading

WednesdayJun 05, 2024 3:15 pm

NetworkNewsBreaks – Sharps Technology Inc. (NASDAQ: STSS) Files Forms for Reg A+ Offering with SEC

Sharps Technology (NASDAQ: STSS), a medical device company, has announced a Reg A+ warrant inducement offering. The offering, which was announced earlier this week, is estimated to reach approximately $2.2 million. The company has filed the required forms for the offering with the U.S. Security Exchange Commission (“SEC”). According to the announcement, Aegis Capital Corp. is acting as the exclusive placement agent for the offering. Aegis Capital Corp. has been in the wealth-management and investment-banking business for four decades. To view more information, visit https://nnw.fm/5OLm6 About Sharps Technology Inc. Sharps Technology, a medical device company, engages in the design, research…

Continue Reading

WednesdayJun 05, 2024 3:06 pm

NetworkNewsBreaks – Alternative Products Expo Returns to Texas for Flagship Global Counterculture Event

Alternative Products Expo (Alt Pro Expo) is preparing to kick off its next in a series of blowout events across North and South America. Presented by ZJ Evets, Alt Pro Expo is slated for June 20–22, 2024, in Houston, Texas. Through the years, Alt Pro Expo has built a reputation for creating a flagship series of events in the global counterculture industry. The agenda for the networking festival includes invaluable education while the exhibit area spotlights an incredible portfolio of innovative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood…

Continue Reading

WednesdayJun 05, 2024 2:51 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well…

Continue Reading